- TypeWebinar
- Location Mayfield, England, United Kingdom
- Date 29-04-2020
Education/Teaching/Training/Development
Commonly found in small molecule drugs, the humble methyl group can have a dramatic effect on binding affinity. A seemingly mundane change from C-H to C-Me can improve IC50 values by orders of magnitude. In addition methylation can have a favourable effect on solubility, off-target selectivity and has been used to introduce a 'metabolic hotspot' for shortening a persistent drugs half-life. Synthetic methods for direct activation and conversion of a C-H to C-Me, particularly in late stage functionalization of complex substrates, continues to be an active area of research in the synthetic community. These methods help drive innovation in medicinal and discovery chemistry.
Abracadabra! In this presentation we reveal some of the magic behind the methyl group, with examples and case studies, and explore state of the art enabling synthetic methodology.
This webinar will be presented by Dr John Studley, Scientific Update. It will take place at the following time:
15.00 GMT (UK, Lisbon)
16.00 CET (Paris, Madrid, Frankfurt etc)
11.00 ET (New York, Boston)
8.00 PT (San Francisco, LA)
Speaker: Dr John Studley Time: 15:00 - 16:00